Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Controlled Clinical Study to Evaluate the Efficacy and Safety of Dissolve™ Compared to SeQuent® Please in Treatment of Coronary In-stent Restenosis in Chinese Population

NCT03373695 is registered in ClinicalTrials.gov with DK Medical Technology (Suzhou) Co., Ltd. as lead sponsor.

NCT NCT03373695
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03373695 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Controlled Clinical Study to Evaluate the Efficacy and Safety of Dissolve™ Compared to SeQuent® Please in Treatment of Coronary In-stent Restenosis in Chinese Population
Lead sponsor
DK Medical Technology (Suzhou) Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
February 22, 2018
Completion date
April 24, 2024
Enrollment
260 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

coronary in-stent restenosis